MSCs in COVID-19 ARDS

Clinical trial NCT04371393 · TERMINATED

Trial details

NCT number: NCT04371393
Sponsor: Icahn School of Medicine at Mount Sinai
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Mesenchymal Stromal Cells Remestemcel-L Acute Respiratory Distress Syndrome COVID

Start date: 2020-04-30
Primary completion: 2021-01-14
Enrollment: 223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.